Our study revealed significantly higher peripheral S100B levels in patients with ADHD compared to controls, strengthening the hypothesis of glial damage within the mechanisms preceding the catecholaminergic disruption responsible for this disorder. Here, S100B is linked to attention deficit-hyperactivity disorder.